Pharma executives make a move: recent appointments

28-Jun-2017 - Last updated on 29-Jun-2017 at 10:12 GMT

Daniel Jorgensen

Ocugen welcomes ex-Pfizer Daniel Jorgensen, the IGBMA’s Biosimilars Committee gets a new chair and drug development consultants Boyds hires two associate directors in one go.

Ocugen: Daniel Jorgensen

Syros Pharmaceuticals: Srinivas Akkaraju

IGBMA: Ingrid Schwarzenberger

Boyds: Elaine Harper & Jayne Hunt

Dragonfly Therapeutics: Nicolai Wagtmann

Products

Saama accelerates data review processes Saama | Download Infographic
More Data, More Insights, More Progress Saama | Download Case Study

Webinars

Upcoming editorial webinars

12 Jun 2024 Wed Webinar Diversity: Increasing trial inclusivity

On-demand webinars

How to reduce crosslinking and ensure fast dissolution in soft caps
Cell and Gene Therapy Manufacturing Webinar
Innovation in Drug Delivery Webinar

Headlines

Inato study digs deep into the global clinical trial marketplace, but what were the main findings?
Geopolitical tensions between the US and China and the effect on life sciences
Could Bayer's non-hormonal elinzanetant signal the end of menopausal hot flushes?
South Rampart Pharma's quest to deliver innovative non-opioid pain solutions
Inceptua improves access to medicine for serious gram-negative bacterial infections in LATAM
Indica Labs'platform cleared by FDA, enhancing pathologists' diagnostic capabilities
Roquette solving toughest drug development challenges with new capsules
First oral treatment for chronic kidney disease launched in China by Everest Medicine
Real-life data highlights need for patient-centered management of unhealthy cholesterol
Sanofi's €1BN investment to enhance health sovereignty in France

Pharma executives make a move: recent appointments

Follow us

Products

Webinars

Headlines

Outsourcing-Pharma

Resources